Variant report
Variant | esv3479350 |
---|---|
Chromosome Location | chr8:63034841-63040500 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190033311 | chr8:63034879-63034880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537645873 | chr8:63034884-63034885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75979427 | chr8:63034913-63034914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571115427 | chr8:63034927-63034928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371663009 | chr8:63034983-63034984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10113426 | chr8:63034992-63034993 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs369093170 | chr8:63035005-63035006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs58882625 | chr8:63035019-63035020 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs372869393 | chr8:63035026-63035027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565523754 | chr8:63035053-63035054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138546357 | chr8:63035055-63035056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555300261 | chr8:63035057-63035058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182098591 | chr8:63035075-63035076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536879194 | chr8:63035088-63035089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544135313 | chr8:63035094-63035095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374794739 | chr8:63035108-63035109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559144774 | chr8:63035121-63035122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187201492 | chr8:63035161-63035162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190112255 | chr8:63035165-63035166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs140706696 | chr8:63035211-63035212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530020035 | chr8:63035220-63035221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386726098 | chr8:63035263-63035264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7832276 | chr8:63035265-63035266 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs145907138 | chr8:63035272-63035273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531456748 | chr8:63035278-63035279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138388535 | chr8:63035305-63035306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555674759 | chr8:63035372-63035373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566412488 | chr8:63035398-63035399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149617426 | chr8:63035399-63035400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369718214 | chr8:63035478-63035479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547157681 | chr8:63035496-63035497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7836117 | chr8:63035504-63035505 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs536246550 | chr8:63035507-63035508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534987220 | chr8:63035558-63035559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555488468 | chr8:63035563-63035564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569670311 | chr8:63035583-63035584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183114161 | chr8:63035584-63035585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188773655 | chr8:63035597-63035598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144262628 | chr8:63035623-63035624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577351148 | chr8:63035663-63035664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558168038 | chr8:63035677-63035678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192873534 | chr8:63035802-63035803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553187261 | chr8:63035852-63035853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574915945 | chr8:63035913-63035914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541924736 | chr8:63036008-63036009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563315633 | chr8:63036017-63036018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530828957 | chr8:63036025-63036026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373898464 | chr8:63036027-63036028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543297230 | chr8:63036112-63036113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565216297 | chr8:63036298-63036299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63034000-63038200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr8:63034200-63036200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr8:63034600-63037400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr8:63037200-63039600 | Enhancers | Brain Germinal Matrix | brain |
5 | chr8:63037400-63038000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:63038200-63038600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr8:63039200-63039400 | Enhancers | Aorta | Aorta |
8 | chr8:63040000-63041400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |